These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 30541855)

  • 21. Human Norovirus Epitope D Plasticity Allows Escape from Antibody Immunity without Loss of Capacity for Binding Cellular Ligands.
    Lindesmith LC; Brewer-Jensen PD; Mallory ML; Yount B; Collins MH; Debbink K; Graham RL; Baric RS
    J Virol; 2019 Jan; 93(2):. PubMed ID: 30355694
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genomic and biological characterization of a pandemic norovirus variant GII.4 Sydney 2012.
    Ge L; Chen X; Liu J; Zheng L; Chen C; Luo S; Guo P; Kong J; Song Y; Huo Y
    Virus Genes; 2020 Apr; 56(2):174-181. PubMed ID: 31912284
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structural analysis of a rabbit hemorrhagic disease virus binding to histo-blood group antigens.
    Leuthold MM; Dalton KP; Hansman GS
    J Virol; 2015 Feb; 89(4):2378-87. PubMed ID: 25505081
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chimeric GII.4 norovirus virus-like-particle-based vaccines induce broadly blocking immune responses.
    Debbink K; Lindesmith LC; Donaldson EF; Swanstrom J; Baric RS
    J Virol; 2014 Jul; 88(13):7256-66. PubMed ID: 24741081
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Flexibility in surface-exposed loops in a virus capsid mediates escape from antibody neutralization.
    Kolawole AO; Li M; Xia C; Fischer AE; Giacobbi NS; Rippinger CM; Proescher JB; Wu SK; Bessling SL; Gamez M; Yu C; Zhang R; Mehoke TS; Pipas JM; Wolfe JT; Lin JS; Feldman AB; Smith TJ; Wobus CE
    J Virol; 2014 Apr; 88(8):4543-57. PubMed ID: 24501415
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Emergence of Novel Human Norovirus GII.17 Strains Correlates With Changes in Blockade Antibody Epitopes.
    Lindesmith LC; Kocher JF; Donaldson EF; Debbink K; Mallory ML; Swann EW; Brewer-Jensen PD; Baric RS
    J Infect Dis; 2017 Dec; 216(10):1227-1234. PubMed ID: 28973354
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structural analysis of determinants of histo-blood group antigen binding specificity in genogroup I noroviruses.
    Shanker S; Czako R; Sankaran B; Atmar RL; Estes MK; Prasad BV
    J Virol; 2014 Jun; 88(11):6168-80. PubMed ID: 24648450
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cross-reactive neutralizing human monoclonal antibodies mapping to variable antigenic sites on the norovirus major capsid protein.
    Ford-Siltz LA; Tohma K; Alvarado GS; Kendra JA; Pilewski KA; Crowe JE; Parra GI
    Front Immunol; 2022; 13():1040836. PubMed ID: 36389818
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Particle conformation regulates antibody access to a conserved GII.4 norovirus blockade epitope.
    Lindesmith LC; Donaldson EF; Beltramello M; Pintus S; Corti D; Swanstrom J; Debbink K; Jones TA; Lanzavecchia A; Baric RS
    J Virol; 2014 Aug; 88(16):8826-42. PubMed ID: 24872579
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nanobodies targeting norovirus capsid reveal functional epitopes and potential mechanisms of neutralization.
    Koromyslova AD; Hansman GS
    PLoS Pathog; 2017 Nov; 13(11):e1006636. PubMed ID: 29095961
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Linear epitope binding antibodies against GII.3 Norovirus exhibit no histo-blood group antigens (HBGAs) blocking effects.
    Ma S; Zhang F; Zheng L; Liu J; Ma J; Chen X; Yang Z; Wang W; Li L; Wang M; Huo Y
    Virus Genes; 2019 Jun; 55(3):280-289. PubMed ID: 30725444
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic and phenotypic characterization of GII-4 noroviruses that circulated during 1987 to 2008.
    Yang Y; Xia M; Tan M; Huang P; Zhong W; Pang XL; Lee BE; Meller J; Wang T; Jiang X
    J Virol; 2010 Sep; 84(18):9595-607. PubMed ID: 20592096
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Emergence of a norovirus GII.4 strain correlates with changes in evolving blockade epitopes.
    Lindesmith LC; Costantini V; Swanstrom J; Debbink K; Donaldson EF; Vinjé J; Baric RS
    J Virol; 2013 Mar; 87(5):2803-13. PubMed ID: 23269783
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Population Genomics of GII.4 Noroviruses Reveal Complex Diversification and New Antigenic Sites Involved in the Emergence of Pandemic Strains.
    Tohma K; Lepore CJ; Gao Y; Ford-Siltz LA; Parra GI
    mBio; 2019 Sep; 10(5):. PubMed ID: 31551337
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biological and immunological characterization of norovirus major capsid proteins from three different genotypes.
    Huo Y; Wan X; Ling T; Shen S
    Microb Pathog; 2016 Jan; 90():78-83. PubMed ID: 26616166
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of a blockade epitope of human norovirus GII.17.
    Yi Y; Wang X; Wang S; Xiong P; Liu Q; Zhang C; Yin F; Huang Z
    Emerg Microbes Infect; 2021 Dec; 10(1):954-963. PubMed ID: 33929932
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chimeric VLPs with GII.3 P2 domain in a backbone of GII.4 VP1 confers novel HBGA binding ability.
    Huo Y; Wang W; Ling T; Wan X; Ding L; Shen S; Huo J; Zhang S; Wang M; Wang Y; Liu Y
    Virus Res; 2016 Sep; 224():1-5. PubMed ID: 27521750
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antigenic Relatedness of Norovirus GII.4 Variants Determined by Human Challenge Sera.
    Dai YC; Zhang XF; Xia M; Tan M; Quigley C; Lei W; Fang H; Zhong W; Lee B; Pang X; Nie J; Jiang X
    PLoS One; 2015; 10(4):e0124945. PubMed ID: 25915764
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Emergence of new pandemic GII.4 Sydney norovirus strain correlates with escape from herd immunity.
    Debbink K; Lindesmith LC; Donaldson EF; Costantini V; Beltramello M; Corti D; Swanstrom J; Lanzavecchia A; Vinjé J; Baric RS
    J Infect Dis; 2013 Dec; 208(11):1877-87. PubMed ID: 23908476
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human Sera Collected between 1979 and 2010 Possess Blocking-Antibody Titers to Pandemic GII.4 Noroviruses Isolated over Three Decades.
    Sharma S; Carlsson B; Czakó R; Vene S; Haglund M; Ludvigsson J; Larson G; Hammarström L; Sosnovtsev SV; Atmar RL; Green KY; Estes MK; Svensson L
    J Virol; 2017 Jul; 91(14):. PubMed ID: 28468886
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.